Purpose: Using a dynamic capabilities lens, this paper aims to study the impact of genomics generally and gene therapy specifically on the rare disease sector of the biopharmaceutical industry. Design/methodology/approach: In this study, 24 genomics-based, rare disease-focused biopharma...